REGENERATIVE MEDICINE

FROM BENCH TO BEDSIDE




Holostem Terapie Avanzate has a highly experienced management team, with a sound know-how derived from a long tenure both in business administration and in academic research, successfully applied since many years in translational medicine.




MANAGEMENT


Paolo Chiesi

Chairman of the

board of directors





Andrea Chiesi

Vice-president





Michele De Luca

Scientific Director




Graziella Pellegrini

QP, R&D Director




Richard Jones

Chief Executive Officer




OUR COMPANY

Holostem Terapie Avanzate is a university spin-off founded in 2008 through the profitable union among Michele De Luca and Graziella Pellegrini, the University of Modena and Reggio Emilia  and Chiesi Farmaceutici S.p.A.

(placeholder)
(placeholder)
(placeholder)
(placeholder)

CELL THERAPY

STEM CELLS

TECHNOLOGY

GENE THERAPY

ABOUT US

(placeholder)



¬© 2017  Holostem Terapie Avanzate S.r.l.


VAT: 03213240363 -

Payed Up Capital: Euro 700.000,00

Companies Register Office - Modena: 03213240363

Registered with the Administrative Economic Register: MO-368370

Company subject to the management and coordination of Valline s.r.l.


MISSION


Provide patients suffering from

severe or rare, untreatable diseases

with stem cell-based advanced therapies

through ethical and scientific excellence

(placeholder)

FOLLOW US ON

SCIENTIFIC BACKGROUND

Michele De Luca and Graziella Pellegrini are internationally recognized as leading scientists

in the field of epithelial stem cell biology aimed at clinical application and played a pivotal role in epithelial stem cell-mediated cell therapy

and gene therapy...

(placeholder)

PUBLICATIONS

Our scientist are author of over 150 peer-reviewed publications in major international journals.

(placeholder)


Holostem Terapie Avanzate Srl

joins Clust-ER Association

"Life Sciences and Wellbeing"


June 2, 2017

NEWS